20 Do regular blood tests on EGFR and ALK inhibitors influence dose and safety?

Lung Cancer 2026

View at publisher

Authors: Shaheer Ali Qureshi, Florence Coath, Tom Newsom‐Davis

DOI: 10.1016/j.lungcan.2026.108969

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Health Systems Economic Evaluations Quality of Life